Masimo (MASI)
(Delayed Data from NSDQ)
$135.24 USD
-0.68 (-0.50%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $135.28 +0.04 (0.03%) 7:26 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
Brokerage Reports
0 items in cart
Masimo Corporation [MASI]
Reports for Purchase
Showing records 381 - 400 ( 481 total )
Company: Masimo Corporation
Industry: Medical - Instruments
Healthcare - 1Q 2013: Quarterly Medical Technology Trading & Acquisition Update
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: Masimo Corporation
Industry: Medical - Instruments
Company: Masimo Corporation
Industry: Medical - Instruments
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Masimo Corporation
Industry: Medical - Instruments
Q4 results roughly in-line net of FX, 2013 EPS guidance below consensus, reducing PT
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: Masimo Corporation
Industry: Medical - Instruments
Good 4Q, Mixed Guidance; Positive Long-Term Thesis; Buy
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: Masimo Corporation
Industry: Medical - Instruments
Preview: 4Q Toward Low-end, Rainbow Below Guidance; Risk/Reward Still Favorable
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: Masimo Corporation
Industry: Medical - Instruments
Company: Masimo Corporation
Industry: Medical - Instruments
Healthcare -4Q 2012: Quarterly Medical Technology Trading & Acquisition Update
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: Masimo Corporation
Industry: Medical - Instruments
Company: Masimo Corporation
Industry: Medical - Instruments
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Masimo Corporation
Industry: Medical - Instruments
Updating Model for Device Tax, Introducing 2014; Good Idea for Next Year
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: Masimo Corporation
Industry: Medical - Instruments
Company: Masimo Corporation
Industry: Medical - Instruments
Company: Masimo Corporation
Industry: Medical - Instruments
Q3 revenue and EPS slightly below expectations, guidance reiterated
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: Masimo Corporation
Industry: Medical - Instruments
Company: Masimo Corporation
Industry: Medical - Instruments
Looking Up for Rainbow - Consistent Outlook; Maintain Buy
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: Masimo Corporation
Industry: Medical - Instruments
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Masimo Corporation
Industry: Medical - Instruments
3Q Preview: Expecting Inline Q, Guidance Unchanged
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: Masimo Corporation
Industry: Medical - Instruments
Company: Masimo Corporation
Industry: Medical - Instruments
Healthcare - 3Q 2012: Quarterly Medical Technology Trading & Acquisition Update
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M